about
First cultivation and characterization of Mycobacterium ulcerans from the environmentGenetic Variation in Autophagy-Related Genes Influences the Risk and Phenotype of Buruli UlcerResponse to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad modelEvidence for an intramacrophage growth phase of Mycobacterium ulcerans.Clinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe PhenotypesLocal and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infectionSpontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig ModelMycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infectionNew foci of Buruli ulcer, Angola and Democratic Republic of Congo.Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer.Immune-evasion Strategies of Mycobacteria and Their Implications for the Protective Immune Response.BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4⁺IL-17⁺TNF⁺IL-2⁺ T cells.IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.Natural based eumelanin nanoparticles functionalization and preliminary evaluation as carrier for gentamicinIncreasing the potential of cell-penetrating peptides for cancer therapy using a new pentagonal scaffoldAntimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infectionK2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis
P50
Q21092307-D41FB214-5639-4216-B834-F0589C57CD1AQ28551704-BC79C84A-36D5-4806-9938-3CEA1113404BQ33631299-75A76D0E-3C8A-463F-A9AE-75C54D7A9202Q34016179-AD4CA180-C075-45E6-B7E2-23CA6E050F94Q34033119-3935423B-63A2-42F1-AC2D-C1517BEBEBD5Q34044493-86E5AE1A-59EF-4149-BDDC-6D81EE86BAF5Q34193844-4F588C08-5B23-41E0-9CA0-FBFF48A53455Q34484489-8A8A5059-4C1C-43D9-8E4B-76E31E16F06DQ34500901-B1AA7C0F-0E9E-4A3B-8593-FADEF4538F86Q34702499-9D9A9B49-029D-487C-A828-15F720774E90Q35689228-E5579331-2A30-4054-B881-BC28DD5D0CF0Q35768998-F07BB436-8707-4058-AF2A-FB520E143011Q35790836-A648FC13-BC52-4D11-AF0A-D7DE7AACCB32Q35857386-B468EE74-803F-4D4D-84EE-A4089EF0C70FQ35949741-1D464AD6-F5DB-4973-926E-F116BE691F04Q37072254-BDB14021-7371-4643-B405-42336F9DA951Q37213976-6AE496B2-23D6-42B3-B527-9C1E4E198593Q40065067-B4977791-05AC-4408-9B82-467B853E2F23Q41635068-E8574EF6-49C5-404C-A098-4793AD5A7A9CQ43222932-16CBF455-6540-484F-B06B-B42D2F8C37BCQ57170682-F6FAC0ED-05DD-4BD6-9381-27B43A4DE8C4Q92046893-37290210-119D-4E97-AC30-8C69463C5947Q92697590-0BE2FEE1-D2F9-47BB-B6F6-0CA18E7E640BQ92946552-B190D1D2-C626-4B14-ABB7-0D96CE013A55
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alexandra G Fraga
@ast
Alexandra G Fraga
@en
Alexandra G Fraga
@es
Alexandra G Fraga
@nl
Alexandra G Fraga
@sl
type
label
Alexandra G Fraga
@ast
Alexandra G Fraga
@en
Alexandra G Fraga
@es
Alexandra G Fraga
@nl
Alexandra G Fraga
@sl
prefLabel
Alexandra G Fraga
@ast
Alexandra G Fraga
@en
Alexandra G Fraga
@es
Alexandra G Fraga
@nl
Alexandra G Fraga
@sl
P106
P21
P31
P496
0000-0003-2029-1629